Tag: Pharmaceutical

Fresenius Kabi
United States

Arunesh Verma Joins Fresenius Kabi USA as President

Verma succeeds John Ducker who will retire after 35 years with Fresenius LAKE ZURICH, Ill. – Fresenius Kabi announced today that Arunesh Verma has joined the company as president of Fresenius Kabi USA and a member of the company’s global Executive Leadership Team, reporting to Pierluigi Antonelli, CEO of Fresenius Kabi. “At the same time, I want to thank John Ducker for his outstanding leadership and achievement … Continue reading Arunesh Verma Joins Fresenius Kabi USA as President

Impact Newswire
United States

Selkirk Pharma Appoints Colleen Dixon as New CEO

SPOKANE, Wash. – Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the appointment of Colleen Dixon as the company’s new Chief Executive Officer. Dixon, who formerly served as Vice President of Program Management at Selkirk Pharma, succeeds Patrick Haffey, the founder of Selkirk Pharma and its Chairman and … Continue reading Selkirk Pharma Appoints Colleen Dixon as New CEO

Impact Newswire
Blue Earth Diagnostics
United States

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer to Lead Company’s Next Phase of Business Growth

− Mr. Campione brings more than 25 years global experience in successful development and commercialization of diagnostic imaging agents and radiopharmaceuticals − − Blue Earth Diagnostics co-founder and former Chief Executive Officer David Gauden, D.Phil., appointed as full-time Chief Executive Officer of sister company Blue Earth Therapeutics − − Executive appointments designed to optimize growth and industry leadership for both Bracco companies − MONROE TOWNSHIP, … Continue reading Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer to Lead Company’s Next Phase of Business Growth

Impact Newswire
Crescita
Global

Crescita to Acquire Strategic Assets of Occy Laboratory

LAVAL, Quebec – Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has agreed to acquire all of the non-real estate business assets of Occy Laboratory Inc., (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”). “This tuck-in acquisition aligns with our long-term vision to become a leading Canadian … Continue reading Crescita to Acquire Strategic Assets of Occy Laboratory

Impact Newswire